NCT04180462

Brief Summary

Washington University will evaluate the effectiveness of a multi-component implementation strategy to increase use of HPV vaccine in primary care practices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 26, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 27, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

January 7, 2020

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 14, 2023

Completed
1 year until next milestone

Results Posted

Study results publicly available

February 20, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 29, 2024

Completed
Last Updated

March 25, 2025

Status Verified

March 1, 2025

Enrollment Period

3.1 years

First QC Date

November 26, 2019

Results QC Date

January 26, 2024

Last Update Submit

March 6, 2025

Conditions

Keywords

Implementation StrategyQuality Improvement

Outcome Measures

Primary Outcomes (2)

  • Initiation of the HPV Vaccine 2-dose Series.

    The proportion of eligible preteens who initiate the HPV vaccine before their 13th birthday, at 24 months, post randomization

    24 months

  • Completion of the HPV Vaccine 2-dose Series.

    The proportion of eligible preteens who complete the HPV vaccine before their 13th birthday, at 24 months, post randomization.

    24 months

Secondary Outcomes (2)

  • Sustainability of the Intervention Benefit for Initiation of the HPV Vaccine.

    36 months

  • Sustainability of the Intervention Benefit for Completion of the HPV Vaccine.

    36 months

Study Arms (2)

Intervention Group

EXPERIMENTAL

Practices randomly assigned to this arm will receive the multi-component intervention.

Other: Practice FacilitationOther: EducationOther: Audit and FeedbackOther: Communication Strategy

Wait list control group

NO INTERVENTION

Practices randomly assigned to this arm will be offered the intervention in the last two years of the study.

Interventions

Practice facilitation to support quality improvement methods to effect practice change to develop a sustainable HPV vaccine delivery system.

Intervention Group

An educational video to increase the provider's knowledge about guideline recommendations and patient and practice benefits of vaccination by age 13.

Intervention Group

Audit and feedback of vaccine coverage to increase motivation to engage in practice change.

Intervention Group

A communication strategy to improve the provider's communication skills and their self-efficacy to address parental hesitation.

Intervention Group

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Practices:
  • Community-based pediatric primary care practices with 2 or more providers.
  • Providers who deliver wellness care to preteens and adolescents.
  • Willingness to participate in the practice facilitator-guided QI process.
  • Providers:
  • Providers who deliver wellness care to preteens and adolescents.
  • Willingness to complete study questionnaires.
  • Willingness to participate in the practice facilitator-guided QI process.

You may not qualify if:

  • Practices and providers may be excluded at the discretion of the PI.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

Related Links

MeSH Terms

Interventions

Educational Status

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation Characteristics

Results Point of Contact

Title
Allison King, M.D., Ph.D., MPH
Organization
Washington University School of Medicine

Study Officials

  • Allison King, M.D., Ph.D., MPH

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 26, 2019

First Posted

November 27, 2019

Study Start

January 7, 2020

Primary Completion

February 14, 2023

Study Completion

April 29, 2024

Last Updated

March 25, 2025

Results First Posted

February 20, 2024

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations